Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
English (EN)
Adults
Children
Pregnant women
Clear all
Type of publications
NITAG documentation
(25)
SAGE documentation
(2)
Topics
Regions
Africa
(2)
Americas
(15)
Europe
(6)
Western Pacific
(2)
Countries
Australia
(2)
Belgium
(2)
Bolivia
(1)
Canada
(4)
Ireland
(2)
Netherlands
(1)
Tanzania (United Republic Of)
(1)
Uganda
(1)
United Kingdom
(1)
United States of America
(10)
Diseases
COVID-19
(12)
Hepatitis A
(1)
Hepatitis B
(1)
Herpes zoster
(1)
Human papillomavirus (HPV)
(2)
Influenza
(4)
Japanese encephalitis
(2)
Malaria
(1)
Meningococcal disease
(1)
Mumps
(1)
Pertussis
(1)
Pneumococcal disease
(6)
Rabies
(1)
RSV (Respiratory syncytial virus)
(2)
Publication date
2023
(5)
2022
(9)
2021
(7)
2020
(1)
2019
(1)
2018
(1)
2017
(1)
2012
(2)
Target population
Adults
(7)
Children
(14)
Pregnant women
(6)
Adolescents
(5)
All age groups
(1)
Healthcare workers
(4)
Newborn
(4)
Older adults
(9)
Risk group
(4)
Available to download in languages
English (EN)
(27)
French (FR)
(8)
Spanish (ES)
(6)
27 results found
2023
∙
NIAC
NIAC RECOMMENDATIONS FOR PASSIVE IMMUNISATION AND VACCINATION AGAINST RESPIRATORY SYNCYTIAL VIRUS IN INFANTS, CHILDREN AND OLDER ADULTS
2023
∙
ACIP
Use of Nirsevimab for the Prevention of Respiratory Syncytial Virus Disease Among Infants and Young Children: Recommendations of the Advisory Committee on Immunization Practices
2023
Pneumococcal vaccination of children in the netherlands
2023
∙
NACI
Public health level recommendations on the use of pneumococcal vaccines in adults, including the use of 15-valent and 20-valent conjugate vaccines
2023
∙
NIAC
Recommendations for COVID-19 vaccination of children aged 6 months to 4 years
2022
∙
TITAG
Introduction of malaria vaccine RTS,S/AS01 for use among children in Tanzania populace
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccine booster doses in children 5 to 11 years of age and concurrent vaccine administration
2022
∙
ACIP
Universal Hepatitis B Vaccination in Adults Aged 19–59 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
ACIP
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022
∙
JCVI
Changes to the childhood immunisation schedule: JCVI statement
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register